StockData
Valneva SE logo

Valneva SE (VALN) income statement

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.34−0.23 (-4.04%)

Close on Nov 18, 2026Market cap $463.35MP/E –Yield –

Valneva SE income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
16.4%
Operating margin
-80.5%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
2.16
Debt to equity
–
Debt to assets
47.4%
Cash to current liabilities
117.6%

Valuation

P/E ratio
–
Price to sales
2.94
Price to book
–
Dividend yield
–

See a number that looks wrong?